logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tianxing Zhou

tianjin medical university cancer institute and hospital
H指数:19
被引数:1,081

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer

CAF衍生的PAI-1作为EGFR配体并促进KRAS突变型胰腺癌的生长

Nature Communications
IF15.7
2026-07-040
OAAI
Yu Wang; Chao Liu; Song Gao; Bo Wang; Hongwei Wang; Zijian Shi; Shunjin Xia; Jiayong Li; Xiaofeng Yao; Xiaofan Guo; Jianwei Zheng; Qianqian Zhou; Zhiqiang Chen; Lei Zheng; Qiang Zhang; Jiang Du; Tianxing Zhou; Zhaoyu Zhang; Weijie Song; Lisha Qi; Yalei Wang; Yuh-Pyng Sher; Min Li; Xuan Zhou; Mien-Chie Hung; Yu Ren; Jihui Hao
Adaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma

适应半胱氨酸限制压力可赋予胰腺导管腺癌一种可靶向的脂质代谢易损性

Nature Communications
IF15.7
2025-12-310
OA
Yunzhan Li; Zekun Li; Qin Li; Dongxiao Sun; Bo Ni; Mingjun Tan; Ashley E. Shay; Min Wang; Chenyang Meng; Guangcong Shen; Boyang Fu; Yueying Shan; Shiqi Zhang; Rifah Rownak Tanshee; Tianxing Zhou; Yongjie Xie; Kun-Ming Chen; Bin Qiao; Yunkun Dang; Scot R. Kimball; Guanshi Zhang; Girish H. Rajacharya; Pankaj K. Singh; Xiuchao Wang; Jihui Hao; Shengyu Yang
HCAR2 Orchestrates an Immunosuppressive Niche and Determines Checkpoint Inhibitor Responsiveness in Esophageal Squamous Cell Carcinoma

HCAR2调控免疫抑制性微环境并决定食管鳞状细胞癌中免疫检查点抑制剂的应答性

Biological Procedures Online
IF4.3
2025-12-190
OAAI
Zekun Li; Guangcong Shen; Xiaoqing Ma; Chenyang Meng; Diliyaer Abudukeremu; Rui Zhao; Zuoyu Chen; Qiang Song; Xiaofan Guo; Tianxing Zhou; Chao Xu; Bo Ni; Yueying Shan; Boyang Fu; Yiheng Chen; Zhansheng Jiang; Yongjie Xie; Kaiyuan Wang; Liangliang Wu; Xiuchao Wang
Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma

识别壶腹腺癌根治性切除术后隐匿高危特征及分层管理策略

CANCER BIOLOGY & MEDICINE
IF8.4
2025-10-150
OAAI
Ma, Xiaoqing; Meng, Chenyang; Shi, Xuejing; Zhang, Zhaoyu; Li, Qiuli; Wang, Hongwei; Liang, Yuexiang; Gao, Song; Wang, Xiuchao; Gao, Chuntao; Wang, Jian; Ma, Weidong; Feng, Yukuan; Li, Shuo; Chen, Xingyun; Li, Wei; Shi, Shangheng; Zhou, Tianxing; Yu, Jun; Hao, Jihui
A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma

一种靶向CD147的小分子抑制剂通过诱导铁死亡来增强吉西他滨在胰腺导管腺癌中的疗效

Cell Reports Medicine
IF10.6
2025-08-190
OAAI
Jiaqi Li; Chaozhe Ma; Pei Cao; Weihua Guo; Pengyu Wang; Yang Yang; Bowen Ding; Fengyi Yin; Zhe Li; Yifei Wang; Shouyi Li; Chongbiao Huang; Xiuchao Wang; Tianxing Zhou; Antao Chang; Liang Zhao; Song Gao; Tiansuo Zhao; Hongwei Wang; Jun Yu; Jingyuan Xu; Yukuan Feng; Jihui Hao
The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinoma

ESE3/EHF的核浓缩物在胰腺导管腺癌中诱导细胞衰老，而不伴随相关的炎症分泌表型。

CANCER LETTERS
IF10.1
2025-02-010
PRE
Zhou, Tianxing; Yan, Jingrui; Xu, Bohang; Zhang, Yu; Mao, Guohua; Xie, Yongjie; Fang, Qingxiao; Wang, Bin; Liu, Ziyun; Zou, Yiping; Zhang, Zhaoyu; Wang, Yifei; Wang, Xiuchao; Zhao, Tiansuo; Wang, Hongwei; Huang, Chongbiao; Feng, Yukuan; Yang, Chao; Gao, Song; Yu, Jun; Hao, Jihui
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2D Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy

硝夫替莫靶向ESE3/EHF抑制CXCR2D中性粒细胞浸润并克服胰腺癌对化疗和免疫疗法的耐药性

GASTROENTEROLOGY
IF25.1
2024-07-013
PRE
Xie, Yongjie; Zhou, Tianxing; Li, Xueyang; Zhao, Kaili; Bai, Weiwei; Hou, Xupeng; Liu, Ziyun; Ni, Bo; Zhang, Zhaoyu; Yan, Jingrui; Wang, Yifei; Jiang, Wenna; Wang, Hongwei; Chang, Antao; Gao, Song; Zhao, Tiansuo; Yang, Shengyu; Huang, Chongbiao; Liu, Jing; Hao, Jihui

研究方向

暂未获取到该数据
J
Jihui Hao
H 指数:38论文数:308被引数:4,625
Y
Yongjie Xie
H 指数:12论文数:66被引数:487
X
Xiuchao Wang
H 指数:38论文数:208被引数:4,165
Z
Zhiyong Cui
H 指数:17论文数:60被引数:969
J
Jing Liu
H 指数:25论文数:134被引数:1,896
王
王文利
H 指数:54论文数:425被引数:8,838
刘源 封面图
刘源
H 指数:67论文数:903被引数:1.7万
X
Xueyang Li
H 指数:18论文数:72被引数:1,333
T
Tiansuo Zhao
H 指数:29论文数:141被引数:2,202
J
Jingrui Yan
H 指数:8论文数:34被引数:246